{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/neurocrine-biosciences-announces-initiation-of-phase-1-clinical-study-evaluating-nbip-2118-a-corticotropin-releasing-factor-type-2-receptor-agonist-302760552.html", "message": "News view counter 699509 successfully enlarged"}